AstraZeneca plans to almost double its sales to $80 billion by 2030, according to a press release issued on Tuesday on the occasion of its investor day.The biopharmaceutical group, which posted sales.
AstraZeneca PLC (LSE:AZN) aims to grow its revenue by about 75% to $80 billion by 2030, driven by the launch of 20 new medicines and growth in its oncology,.
Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.
The FTSE 100 index opened down 29.22.